Official Title
Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers
Brief Summary

The medical and paramedical staff of the front-line services are potentially exposed to SARS-CoV-2. Therefore, despite the application of standard protective measures, it is possible that a certain number of these personnel have already contracted SARS-CoV-2, including in its asymptomatic form. Serological testing in this context would be useful for deploying immune healthcare workers as to limit the risk of viral infection and transmission. Therefore, it is of utmost importance to prove that the serological response entails the production of neutralizing antibodies.

Completed
COVID
Corona Virus Infection

Biological: Specific anti-SARS-CoV-2 antibodies

A serum sample needs to be collected from each participant upon recruitment into the investigation All samples will be tested by the rapid test (Artron, Artron Laboratories, Burnaby, Canada), IgM / IgG which is an antibody capture Immunochromatografac assay for simultaneous detection of IgM and IgG in serum or plasma for COVID -19 in samples.
All samples will be tested for total Immunoglobulins and IgG in samples for COVID-19 virus by Ortho clinical diagnostics chemiluminescent technique (Ortho, Raritan, USA).

Eligibility Criteria

Inclusion Criteria:

- Not previously diagnosed with COVID-19 except for convalescents

- Not currently symptomatic with fever or respiratory symptoms (cough, dyspnea)

Exclusion Criteria:

- Patients with fever or respiratory symptoms (cough, dyspnea)

- Refusal to give informed consent, or contraindication to venipuncture.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 60 Years
Countries
Egypt
Locations

ECRRM
Cairo, Egypt

Faculty of Medicine, Cairo University
Cairo, Egypt

Egyptian Center for Research and Regenerative Medicine
NCT Number
MeSH Terms
Coronavirus Infections
COVID-19
Antibodies